Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
80.28
+3.39 (4.41%)
At close: Nov 13, 2026, 4:00 PM EST
81.22
+0.94 (1.17%)
After-hours: Nov 13, 2026, 7:30 PM EST
Tarsus Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Tarsus Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $103.44. The average 1-year stock price forecast is 28.85% higher than the current stock price, while the lowest is $88 (+9.62%) and the highest is $116 (+44.49%).
Price Target: $103.44 (+28.85%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Tarsus Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 7 | 9 | 9 | 9 |
| Buy | 1 | 1 | 0 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 7 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $110 | Buy | Maintains | $110 | +37.02% | Nov 11, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $94 → $102 | Buy | Maintains | $94 → $102 | +27.06% | Nov 6, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $89 → $97 | Buy | Reiterates | $89 → $97 | +20.83% | Nov 5, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Nov 4, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $100 → $103 | Buy | Maintains | $100 → $103 | +28.30% | Nov 4, 2026 |
Financial Forecast
Revenue This Year
741.50M
from 451.36M
Increased by 64.28%
Revenue Next Year
935.41M
from 741.50M
Increased by 26.15%
EPS This Year
-15.32
from -1.59
EPS Next Year
0.22
from -15.32
EPS and Forward PE are based on non-GAAP adjusted numbers.